RGS17 inhibits tumorigenesis and improves 5-fluorouracil sensitivity in nasopharyngeal carcinoma

BACKGROUND: Nasopharyngeal carcinoma (NPC) is a poorly differentiated malignant tumor, and 5-fluorouracil (5-FU) is one of the most effective chemotherapeutic drugs used for the treatment of NPC. Abnormal expression of RGS17 had been shown to improve the sensitivity of many cancers to chemotherapy;...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Qianqian, Zhang, Niankai, Jiang, Yan, Huang, Yichuan, Lian, Yuan-Yuan, Liu, Tingting, Li, Na, Guan, Ge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223391/
https://www.ncbi.nlm.nih.gov/pubmed/30464507
http://dx.doi.org/10.2147/OTT.S176002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223391/
https://www.ncbi.nlm.nih.gov/pubmed/30464507
http://dx.doi.org/10.2147/OTT.S176002

Ejemplares similares